- Created by David Johnson, last modified by Laura Heermann-Langford on Jun 06, 2022
This work group provides a nexus of communication and bridge to the standards development framework, organizational processes and forums for the clinical community to define content, flow and other domain requirements necessary to the development of robust health data standards. The Council provides a mechanism for clinical domains to develop common approaches to standards-related activities and form consensus on issues of interest among multiple groups.
Liaison Between the Clinical Community and HL7
Outreach to Clinicians to include their expertise in Standards Development
Promote Interoperability Across Healthcare, Research, Public Health, Quality Improvement and other Health Domains through Consensus Standard Data Elements
The Clinical Interoperability Council (CIC) will establish and support a process whereby a master set of data elements with their attributes will be defined and harmonized using a common process and a common set of attributes. The attributes will include a name (terminology), a unique and unambiguous definition, units, data type and complete value sets. The CIC will assure the decision making practices related to ensuring appropriate subject matter expertise and governance models are employed as part of the master set of data elements definition and harmonization of standards as appropriate.
CIC will support decision making practices related to clinical domain requirements developed by this committee. We will also, collaborate and offer support to other working groups when requested.
CIC holds cross-project calls on the 2nd and 4th Thursday of every month at 2:00 ET. In addition, there are specific project (topic) calls, some of which are on a regular meeting schedule and others are held ad hoc and announced on the CIC listserv.
- Second Thursday Monthly Cross-Project Calls = All Thinks Cancer Related: Breast Imaging, ICHOM, mCODE,
- Fourth Thursday Monthly Cross- Project Calls = All Things Registries Collaboration/Harmonization of the Frameworks: CREDS, Vanguard
Time: 02:00 PM Eastern Time (US and Canada)
Breast Imaging: 1st and 3rd Wednesdays: 10:00-11:00 ET https://global.gotomeeting.com/join/116193445 United States: +1 (786) 535-3211Access Code: 116-193-445
ICHOM: 2nd and 4th Wednesdays 10:00-11:00 ET (
CREDS: 2nd and 4th Mondays 12:00-13:00 ET (Teams Meeting Link)
To join a call, visit the Conference Calling Center or reference CIC e-mails
- How to create a Confluence Account, here
HL7 Leadership Announcements
|Position:||Senior Clinical Advisor for Interoperability|
|Department:||Healthcare Strategy, Intersystems|
University of Nebraska Medical Center
Omaha, NE, USA
|Department:||University of Nebraska Medical Center|
|Location:||Omaha, NE, USA|
04-25-2023 CIC Meeting NotesMay 25, 2023 • created by Laura Heermann-Langford
05/11/2023 Q4 WGM MinutesMay 19, 2023 • commented by Shahim Essaid
05/11/2023 Q4 WGM MinutesMay 11, 2023 • created by Russell Leftwich
05.10.2023 May CIC WGM MinutesMay 10, 2023 • updated by Keith W. Boone • view change
05.10.2023 May CIC WGM MinutesMay 10, 2023 • updated by Michelle Currie • view change
2023 May CIC Working Group MeetingMay 01, 2023 • updated by Laura Heermann-Langford • view change
04-13-2023 CIC Meeting NotesApr 13, 2023 • updated by Laura Heermann-Langford • view change
2023-03-23 CIC Meeting NotesMar 26, 2023 • created by Russell Leftwich
(ICHOM) Breast Cancer PCOM Set FHIR IG, March 15th 2023Mar 16, 2023 • updated by Umanga de Silva • view change
ICHOM Breast Cancer PCOM Set, Release 1Mar 14, 2023 • created by Umanga de Silva
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
- No labels